Implantable Devices for the Treatment of Breast Cancer

Overview

Journal J Nanotheranostics

Publisher MDPI

Date 2023 Aug 21

PMID 37600442

Authors

Mohammad Mohtasim Hamid Pial

Asahi Tomitaka

Nezih Pala

Upal Roy

Affiliations

Soon will be listed here.

Abstract

Breast cancer is one of the leading causes of death in the female population worldwide. Standard treatments such as chemotherapy show noticeable results. However, along with killing cancer cells, it causes systemic toxicity and apoptosis of the nearby healthy cells, therefore patients must endure side effects during the treatment process. Implantable drug delivery devices that enhance therapeutic efficacy by allowing localized therapy with programmed or controlled drug release can overcome the shortcomings of conventional treatments. An implantable device can be composed of biopolymer materials, nanocomposite materials, or a combination of both. This review summarizes the recent research and current state-of-the art in these types of implantable devices and gives perspective for future directions.

Citing Articles

The potential of three-dimensional printed stents in post-operative treatment of breast cancer.

Fan J, Wang M, Wang X Biomater Transl. 2024; 5(3):331-333.

PMID: 39734702 PMC: 11681180. DOI: 10.12336/biomatertransl.2024.03.010.

Localized radiotherapy of solid tumors using radiopharmaceutical loaded implantable system: insights from a mathematical model.

Piranfar A, Souri M, Rahmim A, Soltani M Front Oncol. 2024; 14:1320371.

PMID: 38559559 PMC: 10979490. DOI: 10.3389/fonc.2024.1320371.

Survey of Transfer Learning Approaches in the Machine Learning of Digital Health Sensing Data.

Chato L, Regentova E J Pers Med. 2023; 13(12).

PMID: 38138930 PMC: 10744730. DOI: 10.3390/jpm13121703.

Engineering the Tumor Immune Microenvironment through Minimally Invasive Interventions.

Pal K, Sheth R Cancers (Basel). 2023; 15(1).

PMID: 36612192 PMC: 9818918. DOI: 10.3390/cancers15010196.

References

Dong Y, Chin S, Blanco E, Bey E, Kabbani W, Xie X . Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy. Clin Cancer Res. 2009; 15(1):131-9. PMC: 2845536. DOI: 10.1158/1078-0432.CCR-08-1691. View

Camarero-Espinosa S, Carlos-Oliveira M, Liu H, Mano J, Bouvy N, Moroni L . 3D Printed Dual-Porosity Scaffolds: The Combined Effect of Stiffness and Porosity in the Modulation of Macrophage Polarization. Adv Healthc Mater. 2021; 11(1):e2101415. PMC: 11468864. DOI: 10.1002/adhm.202101415. View

Jabir N, Tabrez S, Ashraf G, Shakil S, Damanhouri G, Kamal M . Nanotechnology-based approaches in anticancer research. Int J Nanomedicine. 2012; 7:4391-408. PMC: 3420598. DOI: 10.2147/IJN.S33838. View

Chidambaram M, Manavalan R, Kathiresan K . Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J Pharm Pharm Sci. 2011; 14(1):67-77. DOI: 10.18433/j30c7d. View

Naz S, Shahzad H, Ali A, Zia M . Nanomaterials as nanocarriers: a critical assessment why these are multi-chore vanquisher in breast cancer treatment. Artif Cells Nanomed Biotechnol. 2017; 46(5):899-916. DOI: 10.1080/21691401.2017.1375937. View

Allahverdiyev A, Parlar E, Dinparvar S, Bagirova M, Abamor E . Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects. Artif Cells Nanomed Biotechnol. 2018; 46(sup3):S755-S762. DOI: 10.1080/21691401.2018.1511573. View

Conde J, Oliva N, Zhang Y, Artzi N . Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. Nat Mater. 2016; 15(10):1128-38. PMC: 6594055. DOI: 10.1038/nmat4707. View

Chin A, Jiang S, Jang E, Niu L, Li L, Jia X . Implantable optical fibers for immunotherapeutics delivery and tumor impedance measurement. Nat Commun. 2021; 12(1):5138. PMC: 8390758. DOI: 10.1038/s41467-021-25391-z. View

Tang Y, Wang Y, Kiani M, Wang B . Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer. Clin Breast Cancer. 2016; 16(5):335-343. DOI: 10.1016/j.clbc.2016.05.012. View

10.

Timko B, Dvir T, Kohane D . Remotely triggerable drug delivery systems. Adv Mater. 2010; 22(44):4925-43. DOI: 10.1002/adma.201002072. View

11.

Ohno Y, Ohshima S, Miyamoto A, Kametani F, Ito R, Tsuda B . HER2-antigen-specific humoral immune response in breast cancer lymphocytes transplanted in hu-PBL hIL-4 NOG mice. Sci Rep. 2021; 11(1):12798. PMC: 8211648. DOI: 10.1038/s41598-021-92311-y. View

12.

Wang C, Wang X, Dong K, Luo J, Zhang Q, Cheng Y . Injectable and responsively degradable hydrogel for personalized photothermal therapy. Biomaterials. 2016; 104:129-37. DOI: 10.1016/j.biomaterials.2016.07.013. View

13.

Balaji K, Subramanian B, Yadav P, Anu Radha C, Ramasubramanian V . Radiation therapy for breast cancer: Literature review. Med Dosim. 2016; 41(3):253-7. DOI: 10.1016/j.meddos.2016.06.005. View

14.

Pirmoradi F, Jackson J, Burt H, Chiao M . On-demand controlled release of docetaxel from a battery-less MEMS drug delivery device. Lab Chip. 2011; 11(16):2744-52. DOI: 10.1039/c1lc20134d. View

15.

Kahkonen T, Suominen M, Maki-Jouppila J, Halleen J, Tanaka A, Seiler M . Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone. J Immunol Res. 2019; 2019:4260987. PMC: 6532310. DOI: 10.1155/2019/4260987. View

16.

Lei N, Gong C, Qian Z, Luo F, Wang C, Wang H . Therapeutic application of injectable thermosensitive hydrogel in preventing local breast cancer recurrence and improving incision wound healing in a mouse model. Nanoscale. 2012; 4(18):5686-93. DOI: 10.1039/c2nr30731f. View

17.

El-Ghannam A, Ricci K, Malkawi A, Jahed K, Vedantham K, Wyan H . A ceramic-based anticancer drug delivery system to treat breast cancer. J Mater Sci Mater Med. 2010; 21(9):2701-10. DOI: 10.1007/s10856-010-4121-6. View

18.

Liu R, Wolinsky J, Catalano P, Chirieac L, Wagner A, Grinstaff M . Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapy. Ann Surg Oncol. 2011; 19(1):199-206. DOI: 10.1245/s10434-011-1871-4. View

19.

Menoret S, Ouisse L, Tesson L, Remy S, Usal C, Guiffes A . In Vivo Analysis of Human Immune Responses in Immunodeficient Rats. Transplantation. 2019; 104(4):715-723. PMC: 7147402. DOI: 10.1097/TP.0000000000003047. View

20.

Dhankhar R, Vyas S, Jain A, Arora S, Rath G, Goyal A . Advances in novel drug delivery strategies for breast cancer therapy. Artif Cells Blood Substit Immobil Biotechnol. 2010; 38(5):230-49. DOI: 10.3109/10731199.2010.494578. View